Ana Godinho-Santos has the first degree in Microbiology at Faculdade de Medicina da Universidade de Lisboa (FMUL) in 2009. During her PhD on modulation of HIV-host cell pathways at Faculdade de Farmácia UL, she evaluated the function of specific cellular genes in HIV-1 replication cycle. In the course of her graduate training, she also integrated an international team at INSERM U941 (Institut Universitaire d’Hématologie, Hôpital Saint-Louis, Paris), led by François Clavel. During the last 5 years, she built an interest in teaching during mentoring activities, which drove her to teach some classes in Clinical Immunology modules at FMUL. Meanwhile, she concluded an Executive Master in Management (Universidade Europeia, Laureate International Universities). Ana Godinho-Santos was a post-doctoral researcher at Ana Espada de Sousa Lab, FMUL/Instituto de Medicina Molecular João Lobo Antunes (iMM) for almost 5 years, where the main focus was the role of follicular helper T cells (Tfh) in HIV-1 and HIV-2 infections. This post-doctoral position has granted her the opportunity to participate in many different projects, as illustrated by the study group within the COST Action Mye-EUNITER to standardize the evaluation of human myeloid-derived suppressor cells or the establishment of the immunological study of COVID-19 pneumonia patients. Currently Ana Godinho-Santos is an Auxiliar Researcher at iMed.ULisboa, focused on the immunological impact of COVID-19 in several cohorts and CAR T cell development. After 10 years of experience with flow cytometry, she is also the responsible for the full spectrum cytometer Cytek® Aurora at iMed.ULisboa.